Kenneth Binmoeller, M.D., is recognized nationally and internationally as an authority and leader in advanced endoscopic procedures and endosonography. Dr. Binmoeller founded and directs the Interventional Endoscopy Services Medical Group located at California Pacific Medical Center in San Francisco (CPMC)—the premier referral center in Northern California for patients requiring complex endoscopic therapy, as well as the San Francisco Center for Acid Reflux and Gerd and the San Francisco Institute for Weight Loss. He also is the founder of Endovision, a nonprofit organization that serves as an incubator of interventional endoscopic innovations.

Dr. Binmoeller has been performing complex interventional endoscopic procedures since the late 1980s and has authored more than 200 publications and several books. Dr. Binmoeller is a Fellow of the American College of Gastroenterology (FACG) and the American Society for Gastrointestinal Endoscopy (FASGE). In 2013 the ASGE honored Dr. Binmoeller with the prestigious Master Endoscopist of the Year Award.


  • Dr. Binmoeller is an internationally recognized expert in advanced endoscopic procedures and endosonography. He is board certified in gastroenterology and internal medicine.
  • He investigates new diagnoses and treatments for gastrointestinal (GI) disorders and upper GI tract tumors.
  • Author of more than 200 publications and the book, Therapeutic Endoscopy: Color Atlas of Operative Techniques, Dr. Binmoeller trains and mentors endoscopists from academic and medical centers worldwide.

Dr. Binmoeller lists three career-long passions: endoscopy, innovation, and teaching. Endoscopy is the overriding passion that fuels the rest. He is a “universal endoscopist” with expertise in all aspects of interventional endoscopy. His daily practice inspired innovation to improve outcomes for his patients and enable new procedures. He holds more than 50 patents for novel endoscopic technologies.

Several of Dr. Binmoeller’s inventions have developed into successful commercial products that benefit patients around the world. His first patent, filed in 1998, was for an automated device for endosonography-guided tissue sampling. The patent was assigned to the Olympus Medical Corporation for development and global commercialization of the NA-11J-KB Powershot™ needle. Dr. Binmoeller founded his first company, Xlumena, Inc., in 2004 around a portfolio of inventions for EUS-guided translumenal therapy. Xlumena was acquired in April 2015 by Boston Scientific, which has enabled the global commercialization of the AXIOS lumen-apposing stent™*. Dr. Binmoeller’s second company, EndoSphere, Inc., was created around a group of patents that enable physiologic treatment of obesity and metabolic diseases.  EndoSphere’s Satisphere™ duodenal implant is currently in clinical trials.

Because innovation can only disseminate to benefit patients through teaching, Dr. Binmoeller considers teaching the most rewarding of his passions. He has trained and mentored endoscopists from all corners of the world. In 2002 he started a postgraduate International Scholar’s Program in Advanced Endoscopy at California Pacific Medical Center. His center at CPMC hosts an annual course with live demonstration of new procedures that is transmitted to a large conference center and globally over the internet.

Professional Interests

Interventional endoscopy


Tyberg A, Perez-Miranda M, Sanchez-Ocaña R, Peñas I, de la Serna C, Shah J, Binmoeller K, Gaidhane M, Grimm I, Baron T, Kahaleh M, Endoscopic ultrasound-guided gastrojejunostomy with a lumen-apposing metal stent: a multicenter, international experience. (Opens new window)Endosc Int Open

Teoh AY, Ng EK, Chan SM, Lai M, Moran S, Binmoeller KF, Moon JH, Ho KY, Ex vivo comparison of the lumen-apposing properties of EUS-specific stents (with video). (Opens new window)Gastrointest Endosc

Siddiqui AA, Adler DG, Nieto J, Shah JN, Binmoeller KF, Kane S, Yan L, Laique SN, Kowalski T, Loren DE, Taylor LJ, Munigala S, Bhat YM, EUS-guided drainage of peripancreatic fluid collections and necrosis by using a novel lumen-apposing stent: a large retrospective, multicenter U.S. experience (with videos). (Opens new window)Gastrointest Endosc

  • This field is for validation purposes and should be left unchanged.